Frank Schweizer

8.1k total citations · 1 hit paper
153 papers, 6.7k citations indexed

About

Frank Schweizer is a scholar working on Molecular Biology, Molecular Medicine and Organic Chemistry. According to data from OpenAlex, Frank Schweizer has authored 153 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 63 papers in Molecular Medicine and 56 papers in Organic Chemistry. Recurrent topics in Frank Schweizer's work include Antibiotic Resistance in Bacteria (63 papers), Carbohydrate Chemistry and Synthesis (43 papers) and Antimicrobial Peptides and Activities (37 papers). Frank Schweizer is often cited by papers focused on Antibiotic Resistance in Bacteria (63 papers), Carbohydrate Chemistry and Synthesis (43 papers) and Antimicrobial Peptides and Activities (37 papers). Frank Schweizer collaborates with scholars based in Canada, Japan and United States. Frank Schweizer's co-authors include George G. Zhanel, James A. Karlowsky, Heather J. Adam, Philippe Lagacé‐Wiens, Sheryl Zelenitsky, Ronald Domalaon, Temilolu Idowu, Daryl J. Hoban, Alfred S. Gin and Brandon Findlay and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Frank Schweizer

152 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

2019 311 citations George G. Zhanel, Alyssa Golden et al. Drugs profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Schweizer Canada	39	3.0k	2.8k	1.7k	1.5k	1.3k	153	6.7k
Tony Velkov Australia	52	3.1k 1.1×	4.2k 1.5×	2.6k 1.5×	1.1k 0.7×	600 0.5×	260	9.1k
Françoise Van Bambeke Belgium	54	3.6k 1.2×	3.0k 1.1×	2.5k 1.5×	1.2k 0.8×	742 0.6×	253	9.4k
Xilin Zhao United States	45	3.3k 1.1×	3.4k 1.2×	2.6k 1.5×	487 0.3×	560 0.4×	116	8.2k
David Payne United States	40	2.5k 0.8×	2.0k 0.7×	1.2k 0.7×	616 0.4×	1.1k 0.8×	112	6.4k
Irith Wiegand Canada	21	2.7k 0.9×	1.9k 0.7×	697 0.4×	1.7k 1.1×	949 0.7×	27	6.5k
Thilo Köhler Switzerland	45	4.4k 1.5×	3.2k 1.2×	818 0.5×	872 0.6×	345 0.3×	104	7.1k
Michael Scheld United States	8	1.6k 0.5×	2.5k 0.9×	1.1k 0.7×	562 0.4×	507 0.4×	18	4.9k
Lynn L. Silver United States	36	2.5k 0.8×	1.7k 0.6×	1.0k 0.6×	517 0.3×	894 0.7×	73	5.4k
Marie‐Paule Mingeot‐Leclercq Belgium	41	2.7k 0.9×	1.2k 0.4×	1.3k 0.8×	876 0.6×	485 0.4×	114	6.0k
Malcolm G. P. Page Switzerland	43	2.3k 0.8×	2.3k 0.8×	1.3k 0.8×	295 0.2×	520 0.4×	115	5.1k

Countries citing papers authored by Frank Schweizer

Since Specialization

Citations

This map shows the geographic impact of Frank Schweizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Schweizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Schweizer more than expected).

Fields of papers citing papers by Frank Schweizer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Schweizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Schweizer. The network helps show where Frank Schweizer may publish in the future.

Co-authorship network of co-authors of Frank Schweizer

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Schweizer. A scholar is included among the top collaborators of Frank Schweizer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Schweizer. Frank Schweizer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhanel, George G., Melanie Baxter, Philippe Lagacé‐Wiens, et al.. (2025). Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007–23). Journal of Antimicrobial Chemotherapy. 80(Supplement_2). ii15–ii26. 1 indexed citations

Domalaon, Ronald, et al.. (2024). Exploring Structure–Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria. Antibiotics. 13(1). 43–43. 3 indexed citations

Arthur, Gilbert, et al.. (2024). Enhancing outer membrane permeability of tetracycline antibiotics in P. aeruginosa using TOB–CIP conjugates. RSC Medicinal Chemistry. 15(9). 3133–3146. 1 indexed citations

Dhiman, Shiv, et al.. (2024). Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin. RSC Medicinal Chemistry. 15(3). 1055–1065. 3 indexed citations

Dhiman, Shiv, et al.. (2023). Exploring Antibiotic-Potentiating Effects of Tobramycin–Deferiprone Conjugates in Pseudomonas aeruginosa. Antibiotics. 12(8). 1261–1261. 4 indexed citations

Arthur, Gilbert, et al.. (2023). Amphiphilic tribasic galactosamines potentiate rifampicin in Gram-negative bacteria at low Mg++/Ca++concentrations. Bioorganic & Medicinal Chemistry Letters. 97. 129371–129371. 1 indexed citations

Dhiman, Shiv, et al.. (2023). Guanidinylated Amphiphilic Tobramycin Derivatives Synergize with β-Lactam/β-Lactamase Inhibitor Combinations against Pseudomonas aeruginosa. ACS Infectious Diseases. 9(9). 1754–1768. 5 indexed citations

Dhiman, Shiv, et al.. (2023). Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa. ACS Omega. 8(32). 29359–29373. 3 indexed citations

Karlowsky, James A., Andrew Walkty, Melanie Baxter, et al.. (2022). In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019. Microbiology Spectrum. 10(4). e0172422–e0172422. 15 indexed citations

10.

Golden, Alyssa, Melanie Baxter, James A. Karlowsky, et al.. (2021). Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007–19. JAC-Antimicrobial Resistance. 4(1). dlab197–dlab197. 18 indexed citations

11.

Zhanel, George G., Sheryl Zelenitsky, Courtney K. Lawrence, et al.. (2020). Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia. Drugs. 81(2). 233–256. 37 indexed citations

12.

Yang, Xuan, Temilolu Idowu, Ronald Domalaon, et al.. (2019). Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli. European Journal of Medicinal Chemistry. 175. 187–200. 17 indexed citations

13.

Zhanel, George G., Alyssa Golden, Sheryl Zelenitsky, et al.. (2019). Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Drugs. 79(3). 271–289. 311 indexed citations breakdown →

14.

Domalaon, Ronald, Temilolu Idowu, George G. Zhanel, & Frank Schweizer. (2018). Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?. Clinical Microbiology Reviews. 31(2). 219 indexed citations

15.

Jain, Mayur Vilas, Anna Paczulla, Thomas Klonisch, et al.. (2013). Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. Journal of Cellular and Molecular Medicine. 17(1). 12–29. 194 indexed citations

16.

Zhanel, George G., Heather J. Adam, Melanie Baxter, et al.. (2013). Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. Journal of Antimicrobial Chemotherapy. 68(suppl 1). i7–i22. 118 indexed citations

17.

Findlay, Brandon, George G. Zhanel, & Frank Schweizer. (2012). Neomycin–phenolic conjugates: Polycationic amphiphiles with broad-spectrum antibacterial activity, low hemolytic activity and weak serum protein binding. Bioorganic & Medicinal Chemistry Letters. 22(4). 1499–1503. 27 indexed citations

18.

Findlay, Brandon, et al.. (2012). Guanidylation and Tail Effects in Cationic Antimicrobial Lipopeptoids. PLoS ONE. 7(7). e41141–e41141. 25 indexed citations

19.

Zhanel, George G., James A. Karlowsky, Mel DeCorby, et al.. (2009). Prevalence of Antimicrobial‐Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007). Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A). 16 indexed citations

20.

Schweizer, Frank. (2003). Unusual Amino Acids Accessed Through Sugar-Amino Acid Hybrids and Incorporation into Biologically Active Peptides. Trends in Glycoscience and Glycotechnology. 15(86). 315–328. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact